Ian W. Windsor
Pfizer (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, Chemical Synthesis and Analysis, HIV Research and Treatment, Computational Drug Discovery Methods
Most-Cited Works
- → Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike(2021)127 cited
- → Boronic acid with high oxidative stability and utility in biological contexts(2021)100 cited
- → Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease(2021)79 cited
- → Stereoelectronic Effects Impact Glycan Recognition(2020)62 cited
- → Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid(2018)60 cited
- → Recall of B cell memory depends on relative locations of prime and boost immunization(2022)57 cited
- → Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1(2022)41 cited
- → Fluorogenic Assay for Inhibitors of HIV-1 Protease with Sub-picomolar Affinity(2015)36 cited
- → Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting(2022)34 cited
- → Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation(2017)33 cited